In summary, we can say that CHF CMV+ patients present overexpressed genes of the Th1 pathway, molecules involved in the cytotoxicity of CD4+CD28null cells, molecules related to the activation of CD4+ T-cells and antiapoptotic molecules. The gene discussed is CD4; the disease is congestive heart failure.